Rosy  Wills

Rosy Wills

Followers 0
Following 0
According to the new market research report ECG Market is expected to reach USD 10.3 billion by 2024 from USD 7.5 billion in 2019, at a CAGR of 6.4% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173Factors such as the rising incidence of lifestyle & cardiovascular diseases and increasing geriatric population are expected to propel the growth of the diagnostic electrocardiograph market.Asia Pacific diagnostic ECG market is expected to grow at the highest CAGR during the forecast periodOn the basis of region, the diagnostic ECG market is segmented into North America, Europe, Asia Pacific, and RoW.The Asia Pacific is expected to grow at the highest CAGR during the forecast period.Factors such as growth in the geriatric population, growing incidence of chronic diseases, rising healthcare spending, healthcare reforms for infrastructural development, growing demand for advanced technologies, and less stringent regulations are fueling the demand for diagnostic ECG products and services in this region.PERSONALIZE THIS RESEARCH> Triangulate with your Own Data> Get Data as per your Format and Definition> Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor> Any level of PersonalizationGet 10% FREE Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=173The 3-lead ECG segment is expected to grow at the highest CAGR in the diagnostic ECG market during the forecast periodBy lead type, the diagnostic ECG market is divided into 12-lead, 5-lead, 3-lead, 6-lead, single-lead, and other lead types (15- and 18-lead).The 3-lead segment is expected to grow at the highest CAGR during the forecast period.This positive growth is primarily due to the fact that these leads are used conjointly with various other cardiac diagnostic tests and during medical procedures.The hospitals, clinics, and cardiac centers segment accounted for the largest share of the diagnostic electrocardiograph market in 2018By end user, the market is classified into hospitals, clinics, and cardiac centers; ambulatory surgical centers; and other end users.
Factors such as the growing industrial applications of hyperspectral imaging and increasing funding and investments are driving the growth of the global hyperspectral imaging systems market.According to the new market research report Hyperspectral Imaging Systems Market is projected to reach USD 30.0 billion by 2025 from USD 12.4 billion in 2020, at a CAGR of 19.3%.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=246979343The prominent players in this hyperspectral imaging systems market include Headwall Photonics, Inc. (US), Specim, Spectral Imaging Ltd. (Finland), Corning Incorporated (US), Norsk Elektro Optikk AS (Norway), Raytheon Company (US), Resonon Inc. (US), Telops (Canada), Surface Optics Corporation (US), Applied Spectral Imaging Ltd. (US), ChemImage Corporation (US), Cubert GmbH (Germany), BaySpec, Inc. (US).Between 2017 and 2020, product launches formed the key growth strategy adopted by players such as Headwall Photonics (US), Specim (Finland), Cubert GmbH (Germany), and BaySpec, Inc. (US).Headwall Photonics (US) is one of the prominent players in the hyperspectral imaging systems market.The company offers products for industrial inspection, defense & security, remote sensing, and research applications.The company primarily pursues product launches and expansions as its growth strategy in order to widen its sales and distribution network.Specim, Spectral Imaging (Finland) is a leading manufacturer of hyperspectral imaging instruments and systems.
According to research report the Medical Device Outsourcing Market is expected to reach $91.3 billion by 2024 from an estimated $55.0 billion in 2019, at a CAGR of 10.6%.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170622851 Factors such as increasing automation in the manufacturing of medical devices and advanced technologies integrating electronics and medical devices are expected to drive the growth of the medical device outsourcing market.The increased connectivity and data-gathering capabilities of these technologies make it possible to build high-volume, regulation-compliant manufacturing processes with efficient inventory and production management.With the increasing adoption of Industry 4.0 technologies in manufacturing critical and sophisticated medical devices, the medical device outsourcing market is expected to grow significantly during the forecast period.By service type, the device development and manufacturing services segment is estimated to account for the largest share of this market in 2019 In 2019, the device development and manufacturing services segment is expected to account for the largest share of the global medical device outsourcing market.The IVD devices segment is expected to account for the largest share of the medical device outsourcing market in 2019 In 2019, the IVD devices segment is likely to account for the largest share of the medical device contract manufacturing market.
According to the new market research report In Vitro Toxicity Testing Market is expected to reach USD 14.9 billion by 2025 from an estimated USD 9.1 billion in 2020, at a CAGR of 10.3%.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=209577065The major factors driving the growth of this in vitro toxicity testing market are the opposition to animal testing, technological advancements, and increasing R expenditure to detect toxicity at an early stage during drug development are the primary growth drivers for this market.Asia Pacific is estimated to be the fastest-growing market for in vitro toxicology testing during the forecast periodThe APAC in vitro toxicology testing market is projected to register the highest growth during the forecast period.Factors such as emergence of CROs for outsourcing toxicology-related research projects, opposition to animal testing resulting in the use of alternate methods, increasing pharmaceutical drug pipeline, and growing consumer awareness of product safety are some of the key factors driving the growth of the market in the APAC.Due to covid-19 outbreak, there has been a significant increase in Covid-19 testing and drug research.The research in this area is being further undertaken to understand the dynamics of the infection better, which is expected to propel the in vitro toxicology research field further.On the other hand, we are estimating that the major share of diagnostic assays and molecular testing of Covid-19, along with personalized medicine will grow at a stable pace in the next five years.There is a huge increase of manufacturers that have taken key steps to increase patient access to coronavirus diagnostic testing, vaccine and drug development in laboratories, hospitals, and other testing sites across the country to guide patient care and protect public health.Get 10% FREE Customization on this Research Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=209577065In the toxicity endpoints and tests market, the organ toxicity segment is expected to grow at the highest CAGR during the forecast periodThe organ toxicity segment is expected to grow at the highest CAGR during the forecast period.The growth in this segment can be attributed to factors such as the increasing focus on drug safety and consumer-product safety, along with the need to screen potential drug targets during the early stage of drug development.Based on the technologies used in the in vitro toxicology testing, the cell culture technologies segment is expected to account for the largest share of the in vitro toxicology testing marketThe cell culture technologies segment is estimated to account for the largest market share in 2018.
According to research report the medical image management system market is projected to reach USD 4.40 billion in 2023 from USD 3.04 billion in 2018 at a CAGR of 7.7% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=240573338 Technological advancements in diagnostic imaging modalities and image management software, growing investments in the medical imaging market, government initiatives to encourage EMR adoption, increasing usage of imaging equipment, growing adoption of image management systems by small hospitals and imaging centers, and rapidly growing big data in healthcare are factors driving the growth of the medical image management system market.This large share can be attributed to the fact that that PACS were originally designed keeping in mind individual departmental workflows and hence a large number of PACS were adopted in healthcare facilities.The enterprise PACS market, however, is expected to register the highest CAGR of during the forecast period owing to its ability to allow interoperability by allowing integration of results across different hospital departments, enabling seamless access to all patient information at a single point of interaction.Factors such as technological advancements in PACS; adoption of PACS in new imaging segments such as endoscopy, ophthalmology, mammography, and oncology; growing adoption of PACS by small hospitals and imaging centers; and government initiatives encouraging healthcare IT adoption are driving the growth of the PACS segment.The medical image management system market is segmented on the basis of end users into hospitals, diagnostic imaging centers, and other end users including ambulatory surgical centers (ASCs), small clinics, and contract research organizations (CROs).
According to the new market research report Antimicrobial Susceptibility Testing Market by Product (Manual, Automated Susceptibility Testing System), Type (Antibacterial, Antifungal), Application (Clinical Diagnostics), Method (ETEST, Disk Diffusion), End-User - Global Forecasts to 2025, published by MarketsandMarkets™, the Antimicrobial Susceptibility Testing Market is projected to reach USD 4.2 billion by 2025 from USD 3.2 billion in 2020, at a CAGR of 5.5% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=206359984 The growth of the antibacterial susceptibility testing systems market is mainly driven by the growing number of hospitals across major markets, increasing awareness about diagnosis and the treatment of hospital-acquired infections coupled with the increasing adoption of rapid AST methods.Moreover, rising R investments by the key players operating in the market to develop genetics and genotyping-based AST solutions coupled with growing funding & grants for AST-related research are other important factors to drive the market growth in the near future.Among the manual antimicrobial susceptibility testing products, the susceptibility testing disks segment held a major share of the market in 2019.The high quality, low cost, and ease of use of these products are increasing the adoption of susceptibility testing disks in emerging countries.Some prominent players offering susceptibility testing disks include BD (US), Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories, Inc. (US), and HiMedia Laboratories (India).
According to research report the clinical alarm software market is expected to reach $1,724 million by 2023 from an estimated $457 million in 2018, at a CAGR of 30.4% during the forecast period.Download PDF Brchure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=69939577 The major clinical alarm management market vendors include Koninklijke Philips (Netherlands), Vocera Communications (US), Mobile Heartbeat (US), GE Healthcare (US), Ascom Holdings (Switzerland), Spok, Inc. (US), Bernoulli Enterprise (US), Connexall (Canada), Capsule Technologie (US), and Masimo Corporation (US).Product launches and partnerships and have been the most dominating strategy adopted by major players from 2015 to 2018, which helped them to innovate on their offerings and broaden their customer base.• Based on component, the global clinical alarm software market is segmented into two broad categories based on component, namely— solutions and services.The services segment is expected to grow at the highest CAGR during the forecast period owing to the increasing adoption of clinical alarm management solutions and indispensable and recurring nature of services.• Based on product, the global clinical alarm software market is categorized into nurse call systems, physiological monitors, EMR integration systems, bed alarms, ventilators, and others (infusion pumps and pulse oximeters).
According to research report the global structural heart devices market is projected to reach USD 15.08 billion by 2023 from USD 9.28 billion in 2018, at a CAGR of 10.2%.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=161123753Growth in the structural heart devices market is mainly driven by factors such as the rising prevalence of structural heart diseases, regulatory approvals for new and advanced structural heart devices, favorable reimbursement scenario for structural heart procedures & devices, and increasing awareness about structural heart diseases.North America to dominate the structural heart market in 2018North America is expected to account for the largest share of the structural heart devices market in 2018, followed by Europe.The large share of North America in the global market is attributed to factors such as the rising prevalence of structural heart diseases, favorable reimbursement scenario for structural heart procedures and devices, technological advancements, and development of innovative devices.By procedure, the replacement procedures segment is expected to command the largest share of the structural heart market in 2018On the basis of procedure, the market has been broadly segmented into replacement procedures and repair procedures.The replacement procedures segment is further segmented into TAVR (transcatheter aortic valve replacement) procedures and SAVR (surgical aortic valve replacement) procedures, while the repair procedures segment is subdivided into closure procedures, annuloplasty, valvuloplasty, and TMVR procedures.The replacement procedures segment is expected to account for the largest share of the structural heart devices market in 2018.This can be attributed to the long-term durability of these procedures and the widespread preference for transcatheter replacement.Get 10% FREE Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=161123753The heart valve devices segment is expected to account for the largest share of the structural heart market, by product, in 2018On the basis of products, the structural heart devices market is segmented into heart valve devices, occluders and delivery systems, annuloplasty rings, other devices, and accessories.The heart valve devices segment is further subdivided into transcatheter heart valves and surgical heart valves.
According to the market research report Stable Isotope Labeled Compounds Market is projected to grow at a CAGR of 3.0% during the forecast period to reach USD 312 million by 2024 from USD 269 million in 2019.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=53034199The Factors such as the increase in research activities in the pharmaceutical and biotechnology sector, rising proteomics research, and the rising prevalence of cancer.North America to dominate the Stable Isotope Labeling Market during the forecast periodIn 2019, North America dominated the Stable Isotope Labeled Compounds Market, followed by Europe.The major factors driving the growth of the Stable Isotope Labeling Market include the growth of the pharmaceutical and biopharmaceutical industry, the large nuclear industry in the US, the growth of the Canadian pharmaceutical industry, and the availability of funding in North American countries.The H-2 labeled compounds segment accounted for the largest share of the Stable Isotope Labeled Compounds Market.Based on type, the stable isotope labeled compounds industry is segmented into C-13, N-15, O-18, H-2 (deuterium), and other isotopes.The H-2 labeled compounds segment accounted for the largest share of the stable isotope-labeled compounds market in 2019.The large share of this segment can be attributed to the increasing pharmaceutical research conducted using deuterium and the growing nuclear industry.This growth in this segment is driven primarily by increasing drug research in the pharmaceutical industry and the rising availability of deuterium-labeled compounds.The research segment accounted for the largest share of the Stable Isotope Labeled Compounds Market in 2019.Based on application, the Stable Isotope Labeling Market is segmented into research, clinical diagnostics, industrial applications, and other applications.
The advantages of minimally invasive surgeries over traditional open surgeries and the increasing number of minimally invasive surgical procedures across the globe are the key factors driving market growth.According to research report minimally invasive surgery device market is expected to grow from USD 20.1 billion in 2019 to USD 32.7 billion by 2025, at a CAGR of 8.5%.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=682 By type of surgery, the cardiothoracic surgery segment accounted for the largest share of the global MIS instruments market in 2018.Based on type of surgery, the global minimally invasive surgery device market is divided into cardiothoracic surgery, gastrointestinal surgery, orthopedic surgery, gynecological surgery, cosmetic & bariatric surgery, urological surgery, and other surgeries.The large share of this segment can be attributed to the rising prevalence of cardiac diseases, growing awareness about the benefits of early detection of cardiovascular complications, the growing number of coronary and percutaneous cardiology interventions, and increasing adoption of MIS instruments owing to their convenience and better results as compared to other techniques.Based on end user, the global minimally invasive surgery device market is divided into hospitals and ambulatory surgery centers & clinics.
According to the new market research report the Spinal Surgery Devices Market is projected to reach USD 13.8 billion by 2025 from USD 10.3 billion in 2019, at a CAGR of 5.0%.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=712 The advancements in spine surgeries technologies, such as the development of safer, more effective, advanced, simple, and easy-to-use spinal implants and devices; the increasing incidence of spinal disorders; and the launch of advanced bone grafting products are some of the key factors driving the growth of the Spinal Surgery Devices Market.North America dominates the Spinal Implants Devices Market.The Spinal Surgery Devices Market is segmented into five regional segments, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa.The large share of the North American market can be attributed to its highly developed healthcare infrastructure and reimbursement systems and high patient awareness and physician education.However, the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period, primarily due to the improving healthcare infrastructure, rising awareness, improving reimbursement scenario, and the growing insurance coverage in several APAC countries.The spinal fusion and fixation technologies segment accounted for the largest share of the Spinal Implants Devices Market in 2019.On the basis of technology, the Spinal Surgery Devices Market is segmented into spinal fusion and fixation, vertebral compression fracture treatment, motion preservation/non-fusion, and spinal decompression technologies.The spinal fusion and fixation technologies segment accounted for the largest share of the market in 2019.The large share of this segment can be attributed to the rising incidence of target diseases (such as degenerative disc disease and spinal stenosis) with the growing geriatric population across the globe, a growing number of spinal fusion procedures, and technological advancements in spinal fusion techniques and bone grafting procedures.The open surgeries segment accounted for the largest share of the Spinal Surgery Devices Market in 2019.Based on the type of surgery, the market is segmented into open and minimally invasive surgeries.The open surgeries segment accounted for the largest share of the Spinal Surgery Devices Market in 2019.
According to research report the global contrast media market is expected to reach USD 6.0 billion by 2024 from an estimated USD 5.0 billion in 2019, growing at a CAGR of 3.8% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=911Growth in the contrast agent market can primarily be attributed to factors such as the increasing prevalence of cancer & CVD, regulatory approval of a growing number of contrast agents, and the rising volume of CT & MRI examinations.However, the side effects and allergic reactions associated with contrast agents are expected to limit market growth to a certain extent.North America to dominate the market in 2019North America, Europe, Asia Pacific, and the Rest of the World (RoW) are the regions considered for geographic analysis of the global contrast agent market study.North America is expected to account for the largest share of the global contrast media industry.The large share of North America is attributed to the increasing number of diagnostic imaging units and examinations, growing aging population & rising prevalence of chronic conditions in the US, significant focus & government investments in the field of medical imaging, and increasing research activities in Canada.Get 10% FREE Customization on This Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=911By type, the iodinated contrast media segment is expected to account for the largest share of the contrast media market in 2019Based on type, the contrast media market is segmented into iodinated contrast media, gadolinium-based contrast media, barium-based contrast media, and microbubble contrast media.In 2019, the iodinated contrast media segment is estimated to account for the largest share of the contrast media industry.The large share of this segment can be attributed due to its high usage in CT examinations coupled with the fact that it can be used in almost all body parts.By modality, the X-ray/CT segment is expected to account for the largest share of the market in 2019Based on modality, the market is segmented into X-ray/CT, MRI, and ultrasound procedures.
The advantages of TFF over normal flow filtration (NFF), the increasing adoption of single-use technologies, and increased cGMP adoption are the key factors driving the market growth.According to the new market research report TFF System Market is expected to grow from USD 944 million in 2019 to USD 1,590 million by 2024 at a CAGR of 11.0% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=72081607PES/PS to account for the largest share of the global TFF Market, by material type, in 2019Based on material type, the global TFF System Market is divided into PES/PS, regenerated cellulose, and other materials.The PES/PS segment is expected to account for the largest share of the global market in 2019.The hydrophilic nature of PES/PS, its low protein-binding properties, and wide range of applications, such as ultrafiltration of downstream processing, product concentration, and the filtration of biological and pharmaceutical solutions, is expected to drive the demand for this material.Tangential flow filtration systems segment to account for the largest share of the global TFF Market in 2019Based on the product, the TFF System Market is segmented into systems, membrane filters, and accessories.The systems segment is expected to account for the largest share of the market in 2019, owing to factors such as the increasing use of different single-use systems among end users due to their advantages, such as a reduced need for product validation and cleaning.Bioprocess applications projected to account for the largest application segment of the market in 2019Based on application, the market is segmented into bioprocess applications, viral vector and vaccine purification, and other applications such as drug formulation, blood plasma fractionation, media and buffer preparation, and pharmaceutical water purification.
According to research report the global X-Ray Detectors Market is projected to reach USD 3.8 billion by 2024 from USD 2.8 billion in 2019, at a CAGR of 6.1% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=7004984Factors such as growing public and private investments in digital imaging technologies, declining prices and benefits offered by digital detectors, and reimbursement cuts for analog X-rays are driving the growth of the X-ray detector market.North America will continue to dominate the X-ray detectors market during the forecast periodIn 2019, North America is expected to account for the largest share of the X-ray detectors market.The large share of this region is attributed to factors such as technological innovations, increasing healthcare spending, availability of venture capital and government funding, and increasing incidence of chronic diseases.Europe is expected to account for the second-largest share of the market in 2019.Factors such as advancements in healthcare infrastructure, technological advancements, and favorable venture capital funding are expected to fuel the market growth in this region.Flat-panel detectors (FPDs) to account for the largest share of the X-ray detectors market in 2019Based on type, the X-ray detectors market is segmented into flat-panel detectors (FPDs), computed radiography (CR) detectors, charge-coupled device (CCD) detectors, and line-scan detectors.In 2019, the flat-panel detectors segment is expected to account for the largest share of the X-ray detectors market.The growth in this market is mainly driven by the advantages offered by FPD-based portable digital systems (such as high-quality images, faster scanning, increased patient throughput, and multiple storage options), their decreasing prices, and the growing demand for retrofit FPD-based digital X-ray systems.Medical applications to register the highest growth in the X-ray detectors market during the forecast period.By application, the X-ray detectors market is segmented into medical, dental, security, veterinary, and industrial applications.
According to research report the lab informatics market is estimated to reach USD 3.8 billion by 2024 from USD 2.6 billion in 2019, at a CAGR of 7.5% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=203037633Growth in the lab informatics market is mainly driven by the increasing need for laboratory automation, development of integrated lab informatics solutions, increasing need to comply with regulatory standards, and growing demand in biobanks/biorepositories.On the other hand, the lack of integration standards and high maintenance and service costs are expected to restrain the growth of this market to a certain extent.North America dominated the laboratory informatics solutions market in 2018.In 2018, North America dominated the market, followed by Europe.Growth in the North American market is supported by the growing demand for the integration of laboratory systems, rising government funding for research, growth in biobanks, need for early drug discovery, easy availability of laboratory informatics products and services, and stringent regulatory requirements across industries.The cloud-based models segment is expected to grow at the highest CAGR during the forecast period.On the basis of deployment model, the laboratory informatics market is segmented into on-premise, cloud-based, and remotely hosted models.The cloud-based models segment is expected to grow at the highest CAGR during the forecast period.Factors such as on-demand self-serving analytics, no upfront capital investment for hardware, extreme capacity flexibility, and a pay-as-you-go pricing model will boost the demand for cloud-based laboratory informatics solutions in the coming years.
The growth of the market can be attributed to the initiatives by governments & NGOs to encourage organ donation, increasing investment in cell-based research, increasing prevalence of cardiovascular & respiratory diseases, and developments in biologics manufacturing.The high cost of organ transplantation and organ supply-demand gap, however, are expected to hinder the growth of the market.According to research report the Clinical Perfusion Systems Market is projected to reach USD 1,198.8 million by 2021 from USD 989.4 million in 2016, at a CAGR of 3.9% from 2016 to 2021.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=164273069North America is estimated to account for the largest share of the global Clinical Perfusion Systems Market, followed by Europe.The Asia-Pacific region is expected to witness the highest growth in the market during the forecast period.This growth will be particularly centered on China, Japan, and India.Perfusion systems are used to bypass cardiopulmonary systems in order to treat patients with cardiac and respiratory diseases surgically.Perfusion systems such as heart-lung machines deliver oxygen and remove carbon dioxide in patients when the heart and lungs fail to carry out the process of blood oxygenation.
According to the new market research report Single use Bioreactors Market by Product (System, Media Bag, Filtration Assemblies), Type (Stirred tank, Bubble column), Type of Molecule (MAbs, Vaccine), Cell Type (Mammalian, Bacteria), Application (R), End User (CROs & CMOs) - Global Forecast to 2025, published by MarketsandMarkets™, the market is projected to reach USD 3.9 billion by 2025 from USD 1.7 billion in 2020, at a CAGR of 18.0% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=49113750 The Increasing adoption of SUBs among small companies and startups, reduced automation complexity, ease in the cultivation of marine organisms, reduced energy and water consumption, the growing biologics market, technological advancements in SUBs, and increasing Biopharmaceutical R are factors driving the growth of this market.Single-use bioreactor systems accounted for the largest share of Single-use Bioreactors Market Based on product, the market is categorized into single-use bioreactor systems, single-use media bags, single-use filtration assemblies, and other products such as single-use vessels, tubing, connectors, control systems, and probes/sensors, among others.The single-use bioreactor systems segment dominated the market in 2019.SUB systems offer benefits such as lower capital investment, lower operating expenses, and lower environmental footprint, thus driving the growing adoption of these systems in biopharma applications.The stirred-tank SUBs are highly preferred in the cultivation of aerobic microbial cultures as it promote greater oxygen transfer and reduced engineering challenges such as heat removal, mass transfer, and higher agitation rates.
According to the new market research report eHealth Market is expected to reach USD 132.35 Billion by 2023 from USD 47.60 Billion in 2018, at a CAGR of 22.7%.Factors such as the growing need to manage regulatory compliance through the use of eHealth solutions, the need to curtail escalating healthcare costs, increasing government initiatives supporting the use of eHealth solutions and services, the high prevalence of chronic diseases, shift towards patient-centric healthcare delivery, and rising usage of big data are majorly driving the growth of this market.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=11513143 Based on product and service, the eHealth market is segmented into eHealth solutions and eHealth services.The eHealth services segment is expected to grow at the highest CAGR during the forecast period.This growth can be attributed to factors such as the rising demand for availing medical consultation online, rapidly emerging new technologies in healthcare, the demand for home healthcare services, and the use of telecommunication and multimedia technologies combined within mobile and wireless healthcare delivery systems.By type of eHealth solutions, the chronic care management apps are expected to register the highest CAGR during the forecast period.This can be attributed to the growing incidence of chronic diseases, high penetration of mobiles, and increasing adoption of mHealth solutions owing to various benefits such as ease of use and reduced costs offered by these solutions across the globe.Based on type of eHealth services, the remote monitoring services segment is expected to register the highest CAGR during the forecast period.This can be attributed to the increasing incidence of chronic diseases across the globe and the widespread preference of patients for home healthcare and rehabilitation due to the convenience of these services.Based on end user, the healthcare consumers segment is expected to register the highest CAGR during the forecast period.Factors such as the rising demand for personalized care, increased awareness for telehealth services, and high penetration of digital technologies among consumers are contributing to the high adoption of eHealth solutions among healthcare consumers.
Increasing incidence of sports injuries, growing number of initiatives to increase the awareness about artificial tendons and ligaments, increasing research activities on artificial tendons and ligaments, increasing preference for minimally invasive surgeries, benefits of artificial tendons and ligaments, and the issues related to the use of orthobiologics are expected to drive the growth of the artificial tendons and ligaments market.According to research report Artificial Tendons and Ligaments Market is expected to reach USD 35.0 million by 2023 from USD 18.5 million in 2018, at a CAGR of 13.6%Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=176955103 The artificial tendons and ligaments market is emerging and fragmented in nature with various regional and international players.In 2017, the artificial tendons and ligaments market was dominated by LARS (France) and Neoligaments (UK).The artificial tendons and ligaments market is segmented on the basis of application and region.Based on application, the market is segmented into knee injuries, shoulder injuries, foot and ankle injuries, and other injuries (spine and hip injuries).Get Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=176955103 Geographic segments in this report include North America, Europe, Asia Pacific, and RoW.Of these, Europe is expected to account for the largest share of the market in 2018.
According to a new market research report Operating Room Integration Market is projected to grow at a CAGR of 12.4% during the forecast period, to reach USD 1.7 billion by 2024 from USD 1.0 billion in 2019.The growth in this market is driven by the increasing adoption of minimally invasive surgical procedures, redevelopment projects & funding for improving OR infrastructure, and rising need to curtail healthcare costs.Also, emerging economies (such as China, India, Brazil, and Mexico) are expected to offer lucrative growth opportunities for market players during the forecast period.Other factors augmenting market growth in this region are the ongoing expansion of the healthcare infrastructure as well as growing market availability of advanced surgical technologies in Brazil and other Latin American countries, ongoing initiatives of governments to enhance their respective healthcare systems and growing public-private investments for purchasing medical equipment.Stryker Corporation (US), STERIS (US), KARL STORZ (Germany), and Olympus (Japan) are the key players operating in this market.Other prominent players in the market include Getinge (Sweden), Alvo Medical (Poland), Skytron (US), Merivaara (Finland), Brainlab (Germany), TRILUX Medical (Germany), caresyntax (US), Sony (Japan), Barco (Belgium), Arthrex (US), and Richard Wolf (Germany).Stryker dominated the global operating room integration market in 2018.The company offers OR integration solutions through its Endoscopy division.
More

Top